I am not a doctor, ours is a pediatric study, theirs is for adults, they have another phase 2/3 pediatric study in progress, it should be compared with that when the data comes out
https://www.anavex.com/anavex-life-...he-treatment-of-adult-patients-with-rett-syn/
https://www.neurenpharma.com/irm/PD...ificantclinicalbenefitinpediatricRettsyndrome
https://www.clinicaltrials.gov/ct2/...&cond=Rett Syndrome&draw=2&rank=1
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
$14.28 |
Change
0.080(0.56%) |
Mkt cap ! $1.777B | |||
| Open | High | Low | Value | Volume |
| $14.22 | $14.55 | $14.10 | $4.611M | 320.2K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 6352 | $14.28 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $14.38 | 4000 | 1 |
View Market Depth
| Last trade - 16.10pm 04/07/2025 (20 minute delay) ? |
| NEU (ASX) Chart |